In a retrospective cohort of patients with B-ALL receiving oral vancomycin after CD19 CAR-T cell therapy, higher CAR-T cell expansion and serum inflammatory cytokines were observed [108]. Here, CD19 is linked to acute lymphoblastic leukemia.